Table 2.

Patient sample considered for data analysis and relative progression of IBD pathology.

Patient Number	IBD	Therapy	HBI (${\mathit{t}}_0$$\text{-}{\mathit{t}}_1$$\text{-}{\mathit{t}}_2$)	PMS (${\mathit{t}}_0$$\text{-}{\mathit{t}}_1$$\text{-}{\mathit{t}}_2$)
1	UC	Naïve		8-4-4
2	UC	Naïve		8-2-2
3	CD	Naïve	6-6-4
4	UC	Anti-TNF		6-3-4
5	CD	Naïve	7-5-1
6	CD	Anti-TNF	5-4-3
7	UC	Anti-TNF		11-1-2
8	CD	Naïve	10-1-0
9	UC	Anti-TNF		9-3-2
10	UC	Naïve		7-3-2
11	UC	Anti-TNF		6-6-4